Antiretroviral Improvement Among Medicaid Enrollees

Part of paid clinical trials in Richmond, Virginia.

Sponsor
Virginia Commonwealth University
Study ID
NCT05477485
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
19 Years - 64 Years
Healthy Volunteers
Not accepted

Interventions

  • Experimental: AIMS program - patient — BEHAVIORAL
    Patient-level support will be offered to eligible Virginia Medicaid enrollees who have a late ART prescription refill(s) by \>30 days. Support will come from the provider, pharmacy, managed care organization or the community. Patient-level support will involve direct linkages and referrals for participants with a late ART prescription refill(s) \>30-60 days. Support will intensify as the gap in ART prescription(s) fills increases. For those with a late ART prescription refill(s) for \>60 days, added patient-level support will include warm health technology via PositiveLinks, a mobile app program promoting better health through self-monitoring tools, educational resources, direct messaging with program staff and a confidential user community board.
  • No Intervention/Usual care — OTHER
    Participants in the usual care arm will receive standard state-level care for late ART prescription refill(s) for Virginia Medicaid enrollees living with HIV.

Study Details

This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.

Key Dates

Start date
Apr 27, 2023
Status verified
Oct 2025
Primary completion
May 31, 2024
Completion
May 31, 2024

Study Design

Enrollment
4 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Other: Usual Care
    Usual Care participants will receive standard state-level care for missing ART prescription refill(s) for Virginia Medicaid enrollees with HIV.
  • Experimental: AIMS program - patient
    Participants will receive patient-level support. Support will come from the participant's provider, pharmacy, managed-care organization or the community.

Primary Outcome Measure

Number and Percentage of Participants Virally Suppressed [ Time Frame: 3 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Virginia Commonwealth UniversityRichmondVirginia23298-

Find similar trials in Richmond, VA

By condition
HIV
By specialty
Infectious disease
By research site
Virginia Commonwealth University· Richmond, VA

Related Studies